Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 777.59 million compared to INR 641.5 million a year ago. Revenue was INR 788.11 million compared to INR 653.61 million a year ago. Net income was INR 80.98 million compared to INR 45.14 million a year ago. Basic earnings per share from continuing operations was INR 5.08 compared to INR 2.9 a year ago. Diluted earnings per share from continuing operations was INR 5.08 compared to INR 2.9 a year ago.